Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

DSE:SQURPHARMA Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 23, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	197,235	186,953	185,977	192,094	191,030	145,631
Market Cap Growth	1.10%	0.52%	-3.18%	0.56%	31.17%	-30.16%
Enterprise Value	138,170	130,781	132,967	141,464	147,209	111,668
Last Close Price	222.50	200.44	189.51	186.54	180.57	134.54
PE Ratio	8.39	8.93	9.80	10.58	11.98	10.91
Forward PE	8.22	8.30	9.10	9.93	10.40	9.39
PS Ratio	2.60	2.67	3.06	3.34	3.77	3.17
PB Ratio	1.46	1.49	1.61	1.83	2.10	1.88
P/TBV Ratio	1.46	1.49	1.61	1.83	2.10	1.88
P/FCF Ratio	24.07	13.03	32.71	28.71	26.61	16.70
P/OCF Ratio	14.37	10.09	21.76	14.92	17.40	13.54
PEG Ratio	-	0.68	0.70	0.71	0.69	0.63
EV/Sales Ratio	1.82	1.87	2.19	2.46	2.90	2.43
EV/EBITDA Ratio	5.70	6.38	7.00	7.57	8.58	7.07
EV/EBIT Ratio	6.27	7.20	7.97	8.39	9.64	8.05
EV/FCF Ratio	16.86	9.12	23.39	21.14	20.51	12.81
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.00	-
Debt / EBITDA Ratio	0.05	0.07	0.10	0.10	0.01	-
Debt / FCF Ratio	0.12	0.10	0.35	0.29	0.01	-
Asset Turnover	0.56	0.55	0.52	0.56	0.57	0.60
Inventory Turnover	3.11	3.06	3.18	3.72	3.94	4.50
Quick Ratio	9.53	10.70	13.29	14.30	14.56	10.91
Current Ratio	12.12	13.48	16.67	17.03	17.33	14.62
Return on Equity (ROE)	18.33%	17.36%	17.22%	18.52%	18.96%	18.39%
Return on Assets (ROA)	8.61%	8.93%	8.93%	10.17%	10.77%	11.26%
Return on Capital (ROIC)	8.97%	9.29%	9.30%	10.64%	11.34%	11.94%
Return on Capital Employed (ROCE)	13.70%	14.30%	14.20%	15.60%	16.50%	17.70%
Earnings Yield	11.92%	11.19%	10.21%	9.45%	8.35%	9.17%
FCF Yield	4.15%	7.67%	3.06%	3.48%	3.76%	5.99%
Dividend Yield	4.94%	5.49%	5.54%	5.36%	3.32%	3.33%
Payout Ratio	41.49%	44.14%	46.38%	29.20%	24.60%	24.82%
Total Shareholder Return	4.94%	5.49%	5.54%	5.36%	3.32%	3.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.